NewsWorld Congress of Nephrology, May 30-June 4, Hong Kong, China May 08 2013 BioPorto Congress Calendar 2013 April 22 2013 EUROMEDLAB, May 19-23 Milan, Italy April 22 2013 ERA-EDTA CONGRESS, May 18-22, Istanbul, Turkey April 22 2013 World Kidney Day March 14 2013 New overview - NGAL Links and Resources March 08 2013 ISICEM 2013, March 19-22, Brussels Belgium February 27 2013 Conference on Continuous Renal Replacement Therapies, February 12-15, San Diego, CA USA February 07 2013 MEDLAB Middle East / Arab Health, January 28-31, Dubai, UAE January 11 2013 ISNCON, December 6-9 Ahmedabad, India November 29 2012
ERA-EDTA, May 24-27, Paris, France
May 08 2012 by BioPorto Diagnostics
The European Renal Association – European Dialysis and Transplant Association are two of the fastest growing Medical Associations whose purpose are to encourage and to report advances in the field of clinical nephrology, dialysis, renal transplantation and related subjects. A wide variety of lectures and symposia covering the various aspects of basic and clinical nephrology as well as the most recent researches in the field, the ERA-EDTA congress is Europe’s most significant nephrology meeting.
BioPorto will be present at the ERA-EDTA Congress promoting The NGAL Test™. Meet Klaus Boberg Pedersen, Product Manager (firstname.lastname@example.org) and Jakob Ohm Eriksen, Product Manager (email@example.com) at our booth no. 1.G.21.
What is NGAL?
NGAL is a biomarker for diagnosing acute kidney injury (AKI). The biomarker has been recognised by the market as a new way to identify patients at risk of developing potentially severe acute kidney injury (AKI).
To learn more about the ERA EDTA congress please visit: http://eraedta2012.org/